Lantus, the new long-acting insulin
Patients are asking about Lantus, the new long-acting insulin.
Health Canada has approved Lantus (insulin glargine)...but Aventis is delaying the launch until they have adequate supplies.
Insulin glargine is a synthetic insulin that differs from human insulin by 3 amino acids. It forms a microprecipitate in subcutaneous tissue...which delays and prolongs its absorption.